Results 191 to 200 of about 299,280 (207)

Portacaval shunt for familial heterozygous hypercholesterolemia.

Surgery, gynecology & obstetrics, 1981
Two patients with heterozygous familial type 2 hypercholesterolemia are reported upon following treatment with end-to-side portacaval shunting. In both, the portacaval shunt decreased the cholesterol level by about 40 per cent. No adverse effects of the operation could be seen in either patient at 30 months, and no return of cardiovascular disease is ...
openaire   +1 more source

PCSK9 Inhibition With Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: The ODYSSEY KIDS Study

Journal of Clinical Lipidology, 2020
Stephen Daniels, Eric Bruckert, Garen Manvelian   +2 more
exaly  

Recent Progress in Lynch Syndrome and Other Familial Colorectal Cancer Syndromes

Ca-A Cancer Journal for Clinicians, 2018
Patrick Boland, Matthew B Yurgelun, Clement Richard Boland   +2 more
exaly  

Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia

Circulation, 2012
Evan A Stein, Ian Bridges, Frederick J Raal   +2 more
exaly  

Efficacy and Safety of Ezetimibe Monotherapy in Children With Heterozygous Familial or Nonfamilial Hypercholesterolemia

Journal of Pediatrics, 2015
Claude Gagné
exaly  

Prevalence Of Heterozygous Familial Hypercholesterolemia In Kuwait

Atherosclerosis, 2019
R. Al-Laho, Z. Al-Muhanna, J. Hussain, A. Alsarraf   +3 more
openaire   +1 more source

Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects With Heterozygous Familial Hypercholesterolemia

Journal of Pediatrics, 2010
Frederick J Raal, Soamnauth Misir, Jianbo Xu   +2 more
exaly  

Statin Therapy and Risk of Diabetes Mellitus in Aging Patients With Heterozygous Familial Hypercholesterolemia or Familial Combined Hyperlipidemia: A 10-Year Follow-Up

Angiology, 2018
Nikolaos Ioakeimidis, Dimitris Tousoulis, Demosthenes B. Panagiotakos   +2 more
exaly  

The Very High Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia: Analysis of 734 French Patients

Journal of Clinical Lipidology, 2016
Pr Sophie BELIARD, Franck Boccara, Denis Angoulvant   +2 more
exaly  

Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia.

Journal of the American College of Cardiology, 2008
Claude Gagné, Maud N Vissers
exaly